PFIZER LTD (PFIZER) financials
PFIZER LTD (PFIZER) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1]It is the 3rd largest multinational pharmaceutical company in India.[2]
- Market Cap: ₹17,177Cr.
- Current Price: ₹3,755
- Stock P/E: 22.3
- ROE: 18.0%
- ROCE: 24.1%
- Book Value: ₹919
- Dividend Yield: 2.00%
- 52W High / Low: ₹5,448/3,731
In Jun 2026, PFIZER LTD (PFIZER) reported sales ₹653 Cr and net profit ₹204 Cr.
Annual TTM: sales ₹2,570 Cr, net profit ₹735 Cr.
Shareholding: Promoters 63.92% (Sep 2026), FIIs 1.63% (Sep 2026), DIIs 17.52% (Sep 2026), Public 16.93% (Sep 2026), No. of Shareholders 1,04,472% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 589 | 538 | 592 | 603 | 642 | 645 | 629 | 653 |
| Expenses | 399 | 392 | 364 | 393 | 412 | 417 | 393 | 406 |
| Operating Profit | 189 | 146 | 228 | 210 | 230 | 228 | 236 | 248 |
| OPM % | 32% | 27% | 38% | 35% | 36% | 35% | 38% | 38% |
| Other Income | 43 | 43 | 217 | 67 | 42 | -20 | 50 | 45 |
| Interest | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 1 |
| Depreciation | 15 | 15 | 16 | 14 | 14 | 14 | 15 | 14 |
| Profit before tax | 215 | 172 | 426 | 260 | 255 | 192 | 269 | 277 |
| Tax % | 26% | 26% | 22% | 26% | 26% | 26% | 26% | 26% |
| Net Profit | 158 | 128 | 331 | 192 | 189 | 142 | 200 | 204 |
| EPS in Rs | 34.61 | 27.89 | 72.34 | 41.91 | 41.32 | 31.00 | 43.68 | 44.70 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,152 | 2,239 | 2,611 | 2,425 | 2,193 | 2,281 | 2,520 | 2,570 |
| Expenses | 1,578 | 1,526 | 1,775 | 1,616 | 1,555 | 1,540 | 1,615 | 1,628 |
| Operating Profit | 574 | 712 | 836 | 809 | 638 | 742 | 904 | 942 |
| OPM % | 27% | 32% | 32% | 33% | 29% | 33% | 36% | 37% |
| Other Income | 183 | 81 | 63 | 134 | 185 | 344 | 139 | 116 |
| Interest | 11 | 15 | 11 | 13 | 15 | 8 | 10 | 8 |
| Depreciation | 103 | 109 | 115 | 106 | 62 | 61 | 58 | 58 |
| Profit before tax | 642 | 669 | 773 | 824 | 746 | 1,016 | 976 | 993 |
| Tax % | 21% | 26% | 21% | 24% | 26% | 24% | 26% | — |
| Net Profit | 509 | 498 | 613 | 624 | 551 | 768 | 722 | 735 |
| EPS in Rs | 111.29 | 108.77 | 133.90 | 136.38 | 120.52 | 167.79 | 157.92 | 160.70 |
| Dividend Payout % | 297% | 32% | 26% | 29% | 29% | 98% | 48% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves | 2,966 | 3,350 | 2,347 | 2,819 | 3,162 | 3,550 | 4,172 | 4,157 |
| Borrowings | 2 | 2 | 63 | 39 | 41 | 40 | 108 | 70 |
| Other Liabilities | 926 | 1,007 | 810 | 997 | 752 | 593 | 585 | 649 |
| Total Liabilities | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 | 4,911 | 4,922 |
| Fixed Assets | 886 | 973 | 894 | 869 | 749 | 713 | 724 | 678 |
| CWIP | 0 | 1 | 3 | 1 | 8 | 0 | 8 | 20 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3,054 | 3,432 | 2,369 | 3,030 | 3,244 | 3,516 | 4,180 | 4,224 |
| Total Assets | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 | 4,911 | 4,922 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 98 | 323 | 427 | 667 | 356 | 257 | 660 | 968 |
| Cash from Investing Activity | 35 | 1,530 | -469 | -575 | -36 | 54 | -71 | -562 |
| Cash from Financing Activity | -110 | -164 | -1,571 | -181 | -346 | -235 | -205 | -798 |
| Net Cash Flow | 23 | 1,690 | -1,613 | -88 | -26 | 75 | 383 | -392 |
| Free Cash Flow | 125 | 343 | 410 | 654 | 292 | 291 | 783 | 944 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 59% | 93% | 89% | 107% | 81% | 64% | 110% | 105% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
| FIIs | 2.74% | 2.18% | 2.40% | 2.60% | 2.71% | 2.81% | 1.65% | 1.63% |
| DIIs | 16.80% | 17.10% | 17.23% | 17.11% | 17.05% | 16.89% | 17.80% | 17.52% |
| Public | 16.54% | 16.79% | 16.45% | 16.37% | 16.32% | 16.36% | 16.62% | 16.93% |
| No. of Shareholders | 1,05,015 | 1,08,261 | 1,03,222 | 1,03,480 | 1,00,933 | 99,545 | 1,02,478 | 1,04,472 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 29 | 18 | 20 | 23 | 31 | 31 | 26 |
| Inventory Days | 189 | 198 | 199 | 173 | 175 | 200 | 214 | 195 |
| Days Payable | 213 | 197 | 130 | 102 | 91 | 77 | 68 | 89 |
| Cash Conversion Cycle | 6 | 31 | 87 | 91 | 107 | 154 | 177 | 132 |
| Working Capital Days | -16 | -8 | 3 | -14 | 1 | 24 | 23 | 9 |
| ROCE % | 23% | 20% | 23% | 29% | 26% | 22% | 21% | 24% |
Pfizer Ltd
₹17,177Cr.
₹3,755
₹5,448/3,731
22.3
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1]It is the 3rd largest multinational pharmaceutical company in India.[2]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of PFIZER LTD (PFIZER)?
The reported market capitalisation for PFIZER LTD (PFIZER) is ₹17,177Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of PFIZER?
The current price shown for PFIZER LTD (PFIZER) on Fincrux is ₹3,755 with a 52-week high/low of ₹5,448/3,731.
What is the P/E ratio of PFIZER LTD (PFIZER)?
The stock P/E for PFIZER LTD (PFIZER) is 22.3 on Fincrux, with ROE at 18.0% and ROCE at 24.1%.
What were PFIZER latest quarterly results?
For Jun 2026, PFIZER LTD (PFIZER) reported sales ₹653 Cr and net profit ₹204 Cr (figures in ₹ crore unless noted).
What are PFIZER annual sales and net profit?
For TTM, PFIZER LTD (PFIZER) shows sales of ₹2,570 Cr and net profit of ₹735 Cr on the Fincrux profit & loss statement.
Who owns PFIZER LTD (PFIZER)?
Latest shareholding for PFIZER LTD (PFIZER) on Fincrux: Promoters 63.92% (Sep 2026), FIIs 1.63% (Sep 2026), DIIs 17.52% (Sep 2026), Public 16.93% (Sep 2026), No. of Shareholders 1,04,472% (Sep 2026).
Where can I find PFIZER LTD (PFIZER) financials?
PFIZER LTD (PFIZER) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show PFIZER balance sheet and cash flow?
Yes. The PFIZER LTD (PFIZER) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.